David Einhorn's Greenlight Capital adds Kenvue, ETFs and exits Southwestern Energy

Dow Jones02-15

MW David Einhorn's Greenlight Capital adds Kenvue, ETFs and exits Southwestern Energy

By Joy Wiltermuth

David Einhorn's hedge fund Greenlight Capital picked up a new stake in Kenvue Inc. (KVUE) - formerly the consumer healthcare division of Johnson & Johnson $(JNJ)$ - in the fourth quarter, according to a public filing Wednesday.

Greenlight acquired about a $12 million stake in Kenvue in the fourth quarter, while also adding a nearly $2.7 million exposure to Israeli generic-drug giant Teva Pharmaceutical Industries Ltd. $(TEVA)$, according to a 13F quarterly filing with the U.S. Securities and Exchange Commission.

The hedge fund also added exposure to a smattering of exchange-traded funds, while keeping a roughly steady stake in the SPDR Gold shares fund GLD of about $74 million.

Gold prices (GC00) closed at a record high of $2,093.10 an ounce in December, before slipping back to about $2,000 on Wednesday, according to FactSet.

Greenlight exited Activision Blizzard Inc. and Southwestern Energy Co., $(SWN)$ according to the filing.

Einhorn founded Greenlight in 1996 and rose to prominence for shorting stocks, including shares of Lehman Brothers months before the company went bankrupt.

-Joy Wiltermuth

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

February 14, 2024 18:38 ET (23:38 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment